Results 151 to 160 of about 6,238 (230)

THIẾT KẾ, CHẾ TẠO GĂNG TAY HỖ TRỢ PHỤC HỒI CHỨC NĂNG CHO NGƯỜI KHUYẾT TẬT SỬ DỤNG CÁC NGÓN MỀM [PDF]

Bài báo trình bày quy trình thiết kế, chế tạo một găng tay với mục đích tập co bóp phục hồi chức năng và hỗ trợ thao tác cầm nắm vật cho người bị khuyết tật vận động ở bàn tay, sử dụng các ngón mềm.
Mai Văn Linh, Phùng Văn Bình, Trịnh Văn Đức, Trịnh Xuân Hiệp   +3 more
core   +1 more source

EIF5A Couples Translational Control With Transcriptional Reprogramming Through Chromocenter Reorganization During Spermiogenesis

Advanced Science, Volume 13, Issue 9, 13 February 2026.
The translation factor Eukaryotic translation initiation factor 5A (eIF5A) is essential for male fertility in mice. It supports the translation of proteins crucial for heterochromatin organization and acrosome formation. eIF5A deficiency disrupts chromocenter integrity, increases chromatin accessibility, and causes transcriptional dysregulation ...
Yuling Cai, Tongtong Li, Qian Fang, Ziyou Bao, Feng Kong, Huitao Qi, Hanzhen Li, Mingyu Zhang, Wei Wang, Yongxia Guan, Wenbo Liu, Xiangfeng Chen, Zi‐Jiang Chen, Xiaohua Jiang, Xin Wang, Hongbin Liu   +15 more
wiley   +1 more source

Lenacapavir Plus Cabotegravir as Combination Treatment: Real-world Use Cases From the National Clinician Consultation Center. [PDF]

Open Forum Infect Dis
Saberi P, McAnaney C, Nakayoshi A, Bositis C, Gandhi M, Chu C.   +5 more
europepmc   +1 more source

Dynamic Memory‐Augmented Whale Optimization Algorithm (DMA‐WOA) as Feature Descriptor for Polycystic Ovary Syndrome Detection

Applied AI Letters, Volume 7, Issue 1, February 2026.
Proposed approach for this study. ABSTRACT This study introduces a dynamically memory‐adjusted whale optimization algorithm (DMA‐WOA) for feature selection in polycystic ovary syndrome (PCOS) diagnosis. To overcome the standard WOA's limitations in balancing exploration and exploitation, DMA‐WOA incorporated adaptive memory control to improve ...
Daniel Kwame Amissah, Leonard Mensah Boante, Solomon Mensah, Ebenezer Owusu, Justice Kwame Appati   +4 more
wiley   +1 more source

Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions. [PDF]

Curr HIV/AIDS Rep
Saidi F, Hosseinipour MC, Chi BH.
europepmc   +1 more source

Acesso à justiça no Mercosul [PDF]

, 1999
Rodrigues, Horácio Wanderlei
core  

Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy

Cancer Medicine, Volume 15, Issue 2, February 2026.
Among 136 patients with hepatocellular carcinoma (HCC) receiving first‐line systemic therapy (ST), 66 successfully transitioned to subsequent therapies. favourable ALBI scores, earlier TNM stage at the initiation of ST and treatment with immune checkpoint inhibitors (ICIs) were more likely to progress to subsequent therapies.
Kenji Imai, Koji Takai, Masashi Aiba, Shinji Unome, Takao Miwa, Tatsunori Hanai, Hiroyasu Sakai, Yohei Shirakami, Atsushi Suetsugu, Masahito Shimizu   +9 more
wiley   +1 more source

HIV Viral Suppression With Unintentional Lenacapavir Monotherapy in Adherence-Challenged Patients: A Case Series. [PDF]

Open Forum Infect Dis
Mehtani NJ, Grochowski J, Chimezie A, Strough A, Strieff S, Gandhi M.   +5 more
europepmc   +1 more source

An approach to the informal sector in Vietnamese metropolises : from the knowable toward the unknown [PDF]

, 2010
Gubry, Patrick, Lê Thi Huong, Nguyên Thi Thiêng, Pham Thuy Huong   +3 more
core  

Three‐Year Long‐Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Findings regarding long‐term outcomes of unresectable hepatocellular carcinoma (uHCC) patients treated with atezolizumab and bevacizumab (Atez/Bev) have yet to be reported. This study was performed to evaluate results regarding 3 year survival of such patients treated in real‐world clinical settings.
Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Teruki Miyake, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +55 more
wiley   +1 more source